{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:51:12Z","timestamp":1791521472295,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3400700"],"award-info":[{"award-number":["2022YFC3400700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2023ZD0510000"],"award-info":[{"award-number":["2023ZD0510000"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473700"],"award-info":[{"award-number":["82473700"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Institute of Materia Medica Rising-Star Program","doi-asserted-by":"publisher","award":["24QA2701000"],"award-info":[{"award-number":["24QA2701000"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.metabol.2026.156734","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:38:43Z","timestamp":1786491523000},"page":"156734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multi-omics dissection of MASLD reveals divergent pathways to systemic diseases and targets for prevention"],"prefix":"10.1016","volume":"184","author":[{"given":"Yuxuan","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3763-160X","authenticated-orcid":false,"given":"Xingdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5244-6894","authenticated-orcid":false,"given":"Zhenqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2026.156734_bb0005","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2026.156734_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.metabol.2026.156734_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155999","article-title":"Global burden of metabolic diseases, 1990\u20132021","volume":"160","author":"Zhang","year":"2024","journal-title":"Metabolism: clinical and experimental"},{"key":"10.1016\/j.metabol.2026.156734_bb0020","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2026.156734_bb0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2026.156734_bb0030","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","article-title":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","volume":"13","author":"Stefan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2026.156734_bb0035","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1038\/s41591-024-03284-0","article-title":"Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Jamialahmadi","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2026.156734_bb0040","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1038\/s41591-024-03283-1","article-title":"Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Raverdy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2026.156734_bb0045","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2024.06.030","article-title":"Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancer","volume":"81","author":"Ahmed","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2026.156734_bb0050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2026.156734_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155937","article-title":"Obesity and MASLD: is weight loss the (only) key to treat metabolic liver disease?","volume":"157","author":"Huttasch","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156734_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","article-title":"Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies","volume":"150","author":"Clarke","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metabol.2026.156734_bb0065","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1186\/s12967-024-05478-z","article-title":"Polygenic risk score of metabolic dysfunction-associated steatotic liver disease amplifies the health impact on severe liver disease and metabolism-related outcomes","volume":"22","author":"Xiao","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.metabol.2026.156734_bb0070","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2023.05.046","article-title":"Liver disease is a significant risk factor for cardiovascular outcomes - a UK Biobank study","volume":"79","author":"Roca-Fernandez","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2026.156734_bb0075","article-title":"Characterisation of liver fat in the UK Biobank cohort","volume":"12","author":"Wilman","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2026.156734_bb0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","article-title":"Genome-wide characterization of circulating metabolic biomarkers","volume":"628","author":"Karjalainen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156734_bb0085","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156734_bb0090","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1093\/bioinformatics\/bty185","article-title":"Efficient analysis of large-scale genome-wide data with two R packages: bigstatsr and bigsnpr","volume":"34","author":"Prive","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.metabol.2026.156734_bb0095","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/1361\/1\/012015","article-title":"Improved the performance of the K-Means cluster using the sum of squared error (SSE) optimized by using the Elbow Method","volume":"1361","author":"Nainggolan","year":"2019","journal-title":"J Phys Conf Ser"},{"key":"10.1016\/j.metabol.2026.156734_bb0100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1037\/met0000049","article-title":"The variance of the adjusted Rand index","volume":"21","author":"Steinley","year":"2016","journal-title":"Psychol Methods"},{"key":"10.1016\/j.metabol.2026.156734_bb0105","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/s41467-020-17316-z","article-title":"Non-invasive early detection of cancer four years before conventional diagnosis using a blood test","volume":"11","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2026.156734_bb0110","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jgg.2026.02.004","article-title":"The Taizhou Longitudinal Study: a population-based biobank resource of genetic and biochemical biomarkers for precision medicine in China","volume":"53","author":"Jiang","year":"2026","journal-title":"J Genet Genomics"},{"key":"10.1016\/j.metabol.2026.156734_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.metabol.2026.156734_bb0120","article-title":"Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.metabol.2026.156734_bb0125","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.31771","article-title":"Liver-specific deletion of Mouse Tm6sf2 promotes steatosis, fibrosis, and hepatocellular cancer","volume":"74","author":"Newberry","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156734_bb0130","article-title":"Hepatocyte mARC1 promotes fatty liver disease","volume":"5","author":"Lewis","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.metabol.2026.156734_bb0135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156734_bb0140","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/hmg\/ddab096","article-title":"Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer\u2019s disease and myocardial infarction","volume":"30","author":"Palmer","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2026.156734_bb0145","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00535-017-1402-6","article-title":"Slow-metabolizing ADH1B and inactive heterozygous ALDH2 increase vulnerability to fatty liver in Japanese men with alcohol dependence","volume":"53","author":"Yokoyama","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.metabol.2026.156734_bb0150","article-title":"Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPAR\u03b3 and SREBP2","volume":"5","author":"Wang","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.metabol.2026.156734_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163624","article-title":"Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy","volume":"8","author":"Li","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2026.156734_bb0160","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/hep.29336","article-title":"Argininosuccinate synthase 1 (ASS1): a marker of unclassified hepatocellular adenoma and high bleeding risk","volume":"66","author":"Henriet","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156734_bb0165","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","article-title":"Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2026.156734_bb0170","doi-asserted-by":"crossref","first-page":"eaeb5665","DOI":"10.1126\/sciadv.aeb5665","article-title":"Cross-trait genomic modeling reveals the polygenic architecture and systemic impact of MASLD","volume":"12","author":"Du","year":"2026","journal-title":"Sci Adv"},{"key":"10.1016\/j.metabol.2026.156734_bb0175","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.metabol.2026.156734_bb0180","article-title":"Machine learning enables new insights into genetic contributions to liver fat accumulation","volume":"1","author":"Haas","year":"2021","journal-title":"Cell Genom"},{"key":"10.1016\/j.metabol.2026.156734_bb0185","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.31229","article-title":"Genetic pathways in nonalcoholic fatty liver disease: insights from systems biology","volume":"72","author":"Sookoian","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156734_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156306","article-title":"Impact of metabolic dysfunction severity in steatotic liver disease and its interaction with liver fibrosis on all-cause mortality and multiple hepatic and extra-hepatic outcomes","volume":"170","author":"Cuthbertson","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156734_bb0195","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.28142","article-title":"The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: a meta-analysis","volume":"62","author":"Pirola","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2026.156734_bb0200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/eurheartj\/ehx662","article-title":"Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279013 individuals","volume":"39","author":"Lauridsen","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.metabol.2026.156734_bb0205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13195-024-01498-5","article-title":"Association of MAFLD and MASLD with all-cause and cause-specific dementia: a prospective cohort study","volume":"16","author":"Bao","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.metabol.2026.156734_bb0210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4291\/wjgp.v12.i2.14","article-title":"Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population","volume":"12","author":"Kichloo","year":"2021","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.metabol.2026.156734_bb0215","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1053\/j.gastro.2020.12.023","article-title":"Exome-wide association study on alanine aminotransferase identifies sequence variants in the GPAM and APOE associated with fatty liver disease","volume":"160","author":"Jamialahmadi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2026.156734_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104809","article-title":"Beyond the CNS: the many peripheral roles of APOE","volume":"138","author":"Mart\u00ednez-Mart\u00ednez","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.metabol.2026.156734_bb0225","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156734_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156734_bb0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.metabol.2026.156734_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101722","article-title":"The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326","volume":"72","author":"Ford","year":"2023","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2026.156734_bb0245","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1016\/j.cell.2022.09.031","article-title":"En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH","volume":"185","author":"Kimura","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2026.156734_bb0250","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jhep.2022.11.029","article-title":"Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease","volume":"78","author":"Sanyal","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2026.156734_bb0255","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1152\/physrev.00031.2017","article-title":"The oxytocin receptor: from intracellular signaling to behavior","volume":"98","author":"Jurek","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2026.156734_bb0260","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1158\/0008-5472.CAN-22-3115","article-title":"Targeting the immunoglobulin IGSF9 enhances antitumor T-cell activity and sensitivity to anti-PD-1 immunotherapy","volume":"83","author":"Liu","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2026.156734_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156485","article-title":"CADD-engineered peptide PROTACs efficiently target PCSK9 for hypercholesterolemia in vivo","volume":"176","author":"Fan","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2026.156734_bb0270","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41569-021-00634-0","article-title":"PCSK9-targeted therapies: present and future approaches","volume":"18","author":"Rifai","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.metabol.2026.156734_bb0275","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156734_bb0280","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2026.156734_bb0285","article-title":"Hepato-cardiac interorgan communication controls cardiac hypertrophy via combined endocrine-autocrine FGF21 signaling","volume":"6","author":"Mia","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.metabol.2026.156734_bb0290","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamacardio.2022.2333","article-title":"Joint genetic inhibition of PCSK9 and CETP and the association with coronary artery disease: a factorial Mendelian randomization study","volume":"7","author":"Cupido","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.metabol.2026.156734_bb0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jalz.2017.05.006","article-title":"Plasma apolipoprotein E levels and risk of dementia: a Mendelian randomization study of 106,562 individuals","volume":"14","author":"Rasmussen","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.metabol.2026.156734_bb0300","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:40:03Z","timestamp":1791520803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526002477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":60,"alternative-id":["S0026049526002477"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156734","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics dissection of MASLD reveals divergent pathways to systemic diseases and targets for prevention","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156734"}}